Search filters

Filters
Clear All

Phase

  • 1
  • 4
  • 13
  • 10
  • 3
  • 16
  • 48
  • 2
  • 1
  • 47

Found 48 ne-neurology trials

A listing of ne-neurology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Wearable Assessments in the Clinic and Home in PD (WATCH-PD)
30 years - 99 years
All genders
Observational
The purpose of this study is to evaluate disease progression in persons with early Parkinson disease, as assessed by digital and electronic sensor data collection to be correlated with typical clinical assessments.
 A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)
50 years - 85 years
All genders
Phase 2
Interventional
This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.
 MG0003  A Phase 3  Randomized  Double-Blind  Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients with Generalized Myasthenia Gravis
18 years - 99 years
All genders
Phase 3
This is a Phase 3 study of rozanolixizumab in anti-AChR or anti-MuSK autoantibody-positive patients with generalized MG who experience moderate to severe symptoms and are being considered for treatment with IVIg or PEX. The primary objective of the study is to demonstrate the clinical efficacy of rozanolixizumab in patients with …
 To identify reliable markers of LRRK2 activity in human CSF.
30 years - 99 years
Accepts healthy volunteer
All genders
The purpose of this research study is to evaluate new tests for Parkinson's disease (PD) that may help in developing better treatments.
 For persons with drug-resistant focal onset seizures, a type of Epilepsy, the study of of cvl-865 as adjunctive therapy.
18 years - 99 years
All genders
Phase 2
Interventional
Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures
 A Study of TAK-071 in People With Parkinson Disease
40 years - 85 years
All genders
Phase 2
Interventional
It is hoped that TAK-071 will help people with Parkinson's disease to walk with better balance. The main aim of the study is to check if there is a difference in how participants walk after treatment with TAK-071. Another aim is to see if it improves how participants think and …
 HELIOS- A:A Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
18 years - 85 years
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the efficacy and safety of vutrisiran (ALN-TTRSC02) in patients with hereditary transthyretin amyloidosis (hATTR amyloidosis). Participants will receive vutrisiran or the reference comparator patisiran during the Treatment Period.
 Upregulating action semantics to facilitate naming in aphasia
18 years - 99 years
All genders
Phase 1
The goal of this research is to improve the likelihood of aphasia treatment success by activating brain networks that can compensate for language impairment. We will use non-invasive brain stimulation and gesture-priming paradigms to encourage activation of action knowledge (semantics), which we predict will in turn boost verb retrieval. We …
 An Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
18 years - 99 years
All genders
Interventional
Open label extension trial of CVL-865 in adults with drug-resistant focal onset seizures to learn how well the investigational drug works and how safe it is for long-term epilepsy treatment. Participants will answer questions; undergo physical-neuro exams; vitals; ECG collection; blood draws; urine collection; questions about the study drug; and …
 Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
18 years - 99 years
All genders
Phase 3
Interventional
The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG).
11 - 20 of 48